The tariff classification of a smart medication vial from China
No revocation or modification of this ruling appears in the Customs Bulletin issues read here (Nov 6, 2024 through Nov 18, 2026), where CBP publishes most such actions. That is not confirmation that the ruling is still in effect. Confirm its status with CBP before relying on it (ruling on CBP CROSS).
Ruling text
In your letter dated January 22, 2026, you requested a tariff classification ruling. Descriptive literature was provided for our review. The item under consideration is described as the Farda smart medication vial, which is a portable electronic device comprising a reusable plastic vial enclosure incorporating various electronic components. These components include a printed circuit board assembly (PCBA), a rechargeable battery, sensors, and wireless communication modules.
The device is engineered to store solid oral medications, such as tablets or capsules, and to furnish electronic reminder and monitoring capabilities through the detection and logging of user access to the vial. It is important to note that the device does not automatically dispense, administer, or otherwise alter the medication.
The primary sensing mechanism is facilitated by a load cell, which detects relative weight changes upon the removal of medication, and a load cell amplifier that conditions the resultant signal. Classification under the Harmonized Tariff Schedule of the United States (HTSUS) is made in accordance with the General Rules of Interpretation (GRIs). GRI 1 provides that the classification of goods shall be determined according to the terms of the headings and any relevant section or chapter notes.
In the event the articles cannot be classified solely on the basis of GRI 1, GRIs 2 through 6 may be applied in order, as appropriate. The Explanatory Notes (EN) to the HTSUS, while not legally binding, may also be consulted to aid in classification. The smart medication vial is considered to be a composite good within the meaning of GRI 3. Goods classifiable under GRI 3(b) shall be classified as if they consisted of a material or component which gives them their essential character.
The Explanatory Note to GRI 3(b)(VIII), states that the factors which determine essential character will vary between different kinds of goods. It may for example, be determined by the nature of the materials or components, its bulk, quantity, weight or value, or by the role of a constituent material in relation to the use of the goods.
GRI 3(c) states that when the essential character of a composite good cannot be determined, classification is based on the heading that occurs last in numerical order among those which equally merit consideration. Inasmuch as no one component imparts the essential character to the subject composite item, GRI 3(b) does not apply. It is the opinion of this office that the plastic vial in chapter 39, merits equal consideration to the wireless communication device in chapter 85, and the load cell in chapter 90.
Therefore, classification will be determined based on the competing heading that occurs last in numerical order. GRI 3(c) noted. This is consistent with CBP’s determination in New York Ruling Letter N325560, dated May 11, 2022, where an electronic pill case was classified in Chapter 90 utilizing GRI 3(c).
The text above is an excerpt. The official ruling, with its letterhead, signature and any attachments, is on CBP CROSS (N358120).